Kinsale Capital Reports Robust 2025 Financials, Authorizes $250M Share Buyback, and Boosts Dividend
summarizeSummary
Kinsale Capital Group, Inc. reported strong 2025 financial results, including a 21.4% increase in net income, authorized a new $250 million share repurchase program, and raised its quarterly dividend to $0.25 per share, while also seeing a $140 million legal judgment vacated.
check_boxKey Events
-
Record Financial Performance for 2025
Net income increased by 21.4% to $503.6 million, and underwriting income grew by 19.4% to $389.2 million, demonstrating excellent profitability with a combined ratio of 75.9%.
-
New $250 Million Share Repurchase Program
The Board of Directors authorized a new share repurchase program for up to $250.0 million of common stock, following the exhaustion of the previous $100.0 million program in October 2025. This represents a significant capital allocation to shareholders.
-
Quarterly Dividend Increased by 47%
The Board declared a cash dividend of $0.25 per share, a substantial increase from the previous $0.17 per share, payable on March 12, 2026.
-
$140 Million Legal Judgment Vacated
A significant wrongful death claim against a policyholder, which resulted in a $140 million jury verdict in December 2023, was vacated by the Georgia Court of Appeals in October 2025, with a full retrial ordered. This significantly reduces a major potential liability for the company.
auto_awesomeAnalysis
Kinsale Capital Group, Inc. has delivered exceptionally strong financial results for fiscal year 2025, marked by significant growth in net income and underwriting profit. The company's commitment to shareholder returns is evident with the authorization of a new $250 million share repurchase program and a notable increase in its quarterly cash dividend. Furthermore, a major legal judgment against a policyholder was vacated, significantly reducing a potential liability. This combination of strong operational performance, proactive capital management, and positive legal developments signals robust health and a favorable outlook for investors.
At the time of this filing, KNSL was trading at $373.41 on NYSE in the Finance sector, with a market capitalization of approximately $8.7B. The 52-week trading range was $341.06 to $512.76. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.